When does this change take effect?

This change is effective Dec 19, 2025.

Medicare AdvantageCoverageMedium impact

MA05.053n, Insertion of Implantable Infusion Pumps

Q: Who is affected by this change?

This affects Independence Blue Cross Pain Management, Oncology, Endocrinology, Anesthesiology providers on Medicare Advantage plans.

Independence Blue Cross·Pain Management, Oncology, Endocrinology +1 more·Pharmacy

Effective date

Dec 19, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Medicare Advantage policy MA05.053n for insertion of implantable infusion pumps has been reissued with updates effective December 19, 2025. This is a fresh policy change that may affect coverage, billing, or authorization requirements for implantable infusion pump procedures.

Action Required

Action needed

By December 19, 2025: Billing team must review the complete updated policy MA05.053n for implantable infusion pumps to identify any changes to coverage criteria, prior authorization requirements, or billing guidelines. Access the full policy details from the source URL to determine specific workflow updates needed for Medicare Advantage patients requiring implantable infusion pump procedures.

Related policy hubs

Independence Blue Cross policies Pain Management Oncology Endocrinology Anesthesiology